These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3868471)
21. Evaluation of ofloxacin activity against recent clinical isolates. Nani E; Anzivino D; Lavitola A; Lembo M; Covelli B J Chemother; 1989 Jul; 1(4 Suppl):145-6. PubMed ID: 16312345 [No Abstract] [Full Text] [Related]
22. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method]. Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684 [TBL] [Abstract][Full Text] [Related]
23. [The study of urinary tract infection with a possible cause of fungi and evaluation of the efficacy of 5-FC]. Suzuki K; Tamai H Hinyokika Kiyo; 1985 Oct; 31(10):1885-94. PubMed ID: 3911766 [TBL] [Abstract][Full Text] [Related]
24. Control of oral flora by hibitane and other antibacterial agents. Davies RM Soc Appl Bacteriol Symp Ser; 1974; 3(0):101-10. PubMed ID: 4612717 [No Abstract] [Full Text] [Related]
25. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg]. Guibert J; Kitzis MD; Acar JF Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938 [TBL] [Abstract][Full Text] [Related]
26. [Trial of clinical administration of a new antibacterial substance DL 8280 in pulmonary tuberculosis]. Tsukamura M; Yanase M Kekkaku; 1984 Sep; 59(9):477-81. PubMed ID: 6595460 [No Abstract] [Full Text] [Related]
27. Pazufloxacin Toyama Chemical Co. Johnson AP Curr Opin Investig Drugs; 2000 Sep; 1(1):52-7. PubMed ID: 11249595 [TBL] [Abstract][Full Text] [Related]
28. Ofloxacin in open fractures. Ketterl R; Beckurts T; Stübinger B; Machka K; Claudi B J Chemother; 1989 Jul; 1(4 Suppl):737-8. PubMed ID: 16312615 [No Abstract] [Full Text] [Related]
29. Potentially active antimicrobial agents from 2-benzenesulfonyloxyphenyl-3,1-benzoxazine-4-one derivative. Habib OM; Moawad EB; Girges MM; el-Shafei AM Boll Chim Farm; 1995 Oct; 134(9):503-8. PubMed ID: 8527103 [TBL] [Abstract][Full Text] [Related]
30. Effect of ambient conditions on the antibacterial activity of antibacterial agent based on sodium titanium phosphate. Yan J; Zhai F; Ma P; Zhai L; Ying H Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Mar; 36(2):114-6. PubMed ID: 12410966 [TBL] [Abstract][Full Text] [Related]
31. [Antibacterial effect of the tissue adhesive Fimomed]. Gruhn I; Görg J; Glockmann E; Hörenz D Stomatol DDR; 1974 Nov; 24(11):724-7. PubMed ID: 4218383 [No Abstract] [Full Text] [Related]
32. [In vitro antimycobacterial activity of a new quinolone, T-3761]. Tomioka H; Sato K; Saito H Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982 [TBL] [Abstract][Full Text] [Related]
33. [Studies on 2-hydroxythiobenzamide and 2-hydroxythiobenzanalide. 2. Bacteriostatic properties of the compounds]. Weuffen W; Wagner G; Singer D; Hellmuth L Pharmazie; 1966 Aug; 21(8):477-82. PubMed ID: 4966772 [No Abstract] [Full Text] [Related]
34. In vitro antibacterial activity of ofloxacin against periodontal disease-associated bacteria. Miyake Y; Onoe T; Sagawa H; Takamori A; Suginaka H J Periodontal Res; 1988 May; 23(3):222-3. PubMed ID: 2969974 [No Abstract] [Full Text] [Related]
35. A review of the therapeutic uses of ofloxacin. Giamarellou H; Kanellakopoulou K J Chemother; 1989 Jul; 1(4 Suppl):670-2. PubMed ID: 16312585 [No Abstract] [Full Text] [Related]
36. The pharmacokinetics of ofloxacin in healthy adult male volunteers. Leroy A; Borsa F; Humbert G; Bernadet P; Fillastre JP Eur J Clin Pharmacol; 1987; 31(5):629-30. PubMed ID: 3470180 [No Abstract] [Full Text] [Related]
37. [Prostatic tissue and fluid levels of DL-8280]. Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879 [TBL] [Abstract][Full Text] [Related]
38. Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests. Fang M; Chen JH; Xu XL; Yang PH; Hildebrand HF Int J Antimicrob Agents; 2006 Jun; 27(6):513-7. PubMed ID: 16713190 [TBL] [Abstract][Full Text] [Related]
39. [Quinone derivatives of benzo(g)quinoxaline and of naphtho(2,3-b)-1,4-oxazine with antibacterial and antifungal activity]. Casini G; Claudi F; Felici M; Ferappi M; Grifantini M Farmaco Sci; 1969 Aug; 24(8):732-43. PubMed ID: 5817357 [No Abstract] [Full Text] [Related]